Isabelle Texier-Nogues

USPTO Granted Patents = 16 (Patent Applications = 5)

CIPO Patents = 1

EPO Patents = 18 (Patent Applications = 27)

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

11 out of 4,868

Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives

patents

4 out of 3,559

Commissariat a L'energie Atomique

patents

2 out of 5,069

Centre National De La Recherche Scientifique

patents

4. 2 out of 1,743

Institut National De La Sante Et De La Recherche Medicale

patents

5. 1 out of 1

The Joseph Fourier University of Grenoble

patent

6. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2018

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10092506 - Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsion (2018-10-09),

2. 10016510 - Immunogenic composition in emulsion form (2018-07-10),

3. 9707305 - Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis (2017-07-18),

4. 9463248 - Material, method for preparing same, and uses thereof (2016-10-11),

5. 9421281 - Target vector with activable imaging function (2016-08-23),

6. 9289517 - Fluorescent emulsion of indocyanine green (2016-03-22),

7. 9180210 - Nanocrystal nano-emulsion (2015-11-10),

8. 9072775 - Fluorescent emulsions for optical imaging (2015-07-07),

9. 8653291 - Method for surface functionalization by disubstituted alkynes (2014-02-18),

10. 8652360 - Semiconductor nanocrystals (2014-02-18),

11. 8592619 - Bifunctional molecules comprising a cycloalkyne or heterocycloalkyne group and a redox group (2013-11-26),

12. 8546598 - Silane compounds having a cyclic carbon chain including an alkyne function for functionalizing solid substrates and immobilizing biological molecules on said substrates (2013-10-01),

13. 8541604 - Process for the functionalization of biological molecules (2013-09-24),

14. 8513394 - Saccharide fluorescent substrates, preparation method and uses thereof (2013-08-20),

15. 8076466 - Saccharidic fluorescent substrates, their process of preparation and their use (2011-12-13),

Title: The Innovative Contributions of Isabelle Texier-Nogues

Introduction

Isabelle Texier-Nogues is a prominent inventor based in Grenoble, France. She has made significant contributions to the field of therapeutic agent formulations, holding a total of 16 patents. Her work focuses on the development of innovative solutions that enhance the efficacy of therapeutic agents.

Latest Patents

One of her latest patents is titled "Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsion." This invention relates to a therapeutic agent formulation in the form of a nano-emulsion, which comprises a continuous aqueous phase and at least one dispersed oily phase. The oily phase includes not only the therapeutic agent but also at least one amphiphilic lipid and one solubilizing lipid. The aqueous phase contains at least one polyalkoxylated cosurfactant. Another notable patent is the "Immunogenic composition in emulsion form," which involves an immunogenic composition comprising a continuous aqueous phase and a dispersed phase as droplets.

Career Highlights

Isabelle has worked with esteemed organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and the Commissariat à l'Énergie Atomique. Her experience in these institutions has allowed her to develop and refine her innovative ideas in the field of therapeutic formulations.

Collaborations

Throughout her career, Isabelle has collaborated with talented individuals, including Aude Bernardin and Mathieu Goutayer. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Isabelle Texier-Nogues is a remarkable inventor whose work in therapeutic agent formulations has led to significant advancements in the field. Her innovative patents and collaborations highlight her dedication to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.